The current study included HIV-positive cohorts, with HIV-1 p24 antigen, group O and M, genotypes B/B′, BC, and AE, HIV-2, and low S/Co reactivity (1.0–35.0), to evaluate the sensitivity and detection capability of the LiCA® HIV Ag/Ab assay. This evidence concerns the gene RENBP and breast cancer.